231 related articles for article (PubMed ID: 22924847)
1. Clinicopathological study of Japanese patients with genetic iron overload syndromes.
Hattori A; Miyajima H; Tomosugi N; Tatsumi Y; Hayashi H; Wakusawa S
Pathol Int; 2012 Sep; 62(9):612-8. PubMed ID: 22924847
[TBL] [Abstract][Full Text] [Related]
2. Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders.
Kaneko Y; Miyajima H; Piperno A; Tomosugi N; Hayashi H; Morotomi N; Tsuchida K; Ikeda T; Ishikawa A; Ota Y; Wakusawa S; Yoshioka K; Kono S; Pelucchi S; Hattori A; Tatsumi Y; Okada T; Yamagishi M
J Gastroenterol; 2010 Nov; 45(11):1163-71. PubMed ID: 20533066
[TBL] [Abstract][Full Text] [Related]
3. Genetic background of primary iron overload syndromes in Japan.
Hayashi H; Wakusawa S; Motonishi S; Miyamoto K; Okada H; Inagaki Y; Ikeda T
Intern Med; 2006; 45(20):1107-11. PubMed ID: 17106152
[TBL] [Abstract][Full Text] [Related]
4. Iron overload in the Asian community.
Lok CY; Merryweather-Clarke AT; Viprakasit V; Chinthammitr Y; Srichairatanakool S; Limwongse C; Oleesky D; Robins AJ; Hudson J; Wai P; Premawardhena A; de Silva HJ; Dassanayake A; McKeown C; Jackson M; Gama R; Khan N; Newman W; Banait G; Chilton A; Wilson-Morkeh I; Weatherall DJ; Robson KJ
Blood; 2009 Jul; 114(1):20-5. PubMed ID: 19342478
[TBL] [Abstract][Full Text] [Related]
5. [Non-HFE-related hereditary iron overload].
Aguilar-Martinez P
Presse Med; 2007 Sep; 36(9 Pt 2):1279-91. PubMed ID: 17540536
[TBL] [Abstract][Full Text] [Related]
6. HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening.
Barton JC; Acton RT; Leiendecker-Foster C; Lovato L; Adams PC; McLaren GD; Eckfeldt JH; McLaren CE; Reboussin DM; Gordeuk VR; Speechley MR; Reiss JA; Press RD; Dawkins FW;
Genet Test; 2007; 11(3):269-75. PubMed ID: 17949288
[TBL] [Abstract][Full Text] [Related]
7. Non-HFE hemochromatosis.
Pietrangelo A
Semin Liver Dis; 2005 Nov; 25(4):450-60. PubMed ID: 16315138
[TBL] [Abstract][Full Text] [Related]
8. Hereditary hemochromatosis: mutations in genes involved in iron homeostasis in Brazilian patients.
Santos PC; Cançado RD; Pereira AC; Schettert IT; Soares RA; Pagliusi RA; Hirata RD; Hirata MH; Teixeira AC; Figueiredo MS; Chiattone CS; Krieger JE; Guerra-Shinohara EM
Blood Cells Mol Dis; 2011 Apr; 46(4):302-7. PubMed ID: 21411349
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of participants with self-reported hemochromatosis or iron overload at HEIRS study initial screening.
Barton JC; Acton RT; Leiendecker-Foster C; Lovato L; Adams PC; Eckfeldt JH; McLaren CE; Reiss JA; McLaren GD; Reboussin DM; Gordeuk VR; Speechley MR; Press RD; Dawkins FW;
Am J Hematol; 2008 Feb; 83(2):126-32. PubMed ID: 17726683
[TBL] [Abstract][Full Text] [Related]
10. Non-HFE hepatic iron overload.
Pietrangelo A; Caleffi A; Corradini E
Semin Liver Dis; 2011 Aug; 31(3):302-18. PubMed ID: 21901660
[TBL] [Abstract][Full Text] [Related]
11. Hereditary iron overload: update on pathophysiology, diagnosis, and treatment.
Franchini M
Am J Hematol; 2006 Mar; 81(3):202-9. PubMed ID: 16493621
[TBL] [Abstract][Full Text] [Related]
12. Disruption of hemochromatosis protein and transferrin receptor 2 causes iron-induced liver injury in mice.
Delima RD; Chua AC; Tirnitz-Parker JE; Gan EK; Croft KD; Graham RM; Olynyk JK; Trinder D
Hepatology; 2012 Aug; 56(2):585-93. PubMed ID: 22383097
[TBL] [Abstract][Full Text] [Related]
13. Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis.
Valenti L; Pulixi EA; Arosio P; Cremonesi L; Biasiotto G; Dongiovanni P; Maggioni M; Fargion S; Fracanzani AL
Haematologica; 2007 Aug; 92(8):1037-42. PubMed ID: 17640859
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the HFE, TFR2, and SLC40A1 genes in patients with hemochromatosis.
Del-Castillo-Rueda A; Moreno-Carralero MI; Cuadrado-Grande N; Alvarez-Sala-Walther LA; Enríquez-de-Salamanca R; Méndez M; Morán-Jiménez MJ
Gene; 2012 Oct; 508(1):15-20. PubMed ID: 22890139
[TBL] [Abstract][Full Text] [Related]
15. HFE, SLC40A1, HAMP, HJV, TFR2, and FTL mutations detected by denaturing high-performance liquid chromatography after iron phenotyping and HFE C282Y and H63D genotyping in 785 HEIRS Study participants.
Barton JC; Lafreniere SA; Leiendecker-Foster C; Li H; Acton RT; Press RD; Eckfeldt JH
Am J Hematol; 2009 Nov; 84(11):710-4. PubMed ID: 19787796
[TBL] [Abstract][Full Text] [Related]
16. Hereditary hemochromatosis type 1 phenotype modifiers in Italian patients. The controversial role of variants in HAMP, BMP2, FTL and SLC40A1 genes.
Radio FC; Majore S; Aurizi C; Sorge F; Biolcati G; Bernabini S; Giotti I; Torricelli F; Giannarelli D; De Bernardo C; Grammatico P
Blood Cells Mol Dis; 2015 Jun; 55(1):71-5. PubMed ID: 25976471
[TBL] [Abstract][Full Text] [Related]
17. The molecular pathogenesis of hereditary hemochromatosis.
Babitt JL; Lin HY
Semin Liver Dis; 2011 Aug; 31(3):280-92. PubMed ID: 21901658
[TBL] [Abstract][Full Text] [Related]
18. Hemochromatosis: genetics and pathophysiology.
Beutler E
Annu Rev Med; 2006; 57():331-47. PubMed ID: 16409153
[TBL] [Abstract][Full Text] [Related]
19. A Japanese family with ferroportin disease caused by a novel mutation of SLC40A1 gene: hyperferritinemia associated with a relatively low transferrin saturation of iron.
Koyama C; Wakusawa S; Hayashi H; Ueno T; Suzuki R; Yano M; Saito H; Okazaki T
Intern Med; 2005 Sep; 44(9):990-3. PubMed ID: 16258219
[TBL] [Abstract][Full Text] [Related]
20. [Pathophysiology and genetics of classic HFE (type 1) hemochromatosis].
Loréal O; Ropert M; Mosser A; Déhais V; Deugnier Y; David V; Brissot P; Jouanolle AM
Presse Med; 2007 Sep; 36(9 Pt 2):1271-7. PubMed ID: 17521857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
